Pharma's top 10 M&A deals of 2014's first half
20 November 2014
Mergers and acquisitions have been non-stop this year, with lots of deals done, and some doozies that were unable to cross the finish line. Here we look at what's happened in the first half of the year; we will round out the entire year's activity in another report early next year.
Pharma deploys reps with helping hands to target stealth prescribers
20 November 2014
As physicians pack up camp and move to larger healthcare systems, restrictive policies bar reps from calling on doctors and face-to-face conversations dwindle. But companies may want to invite other members of the office to the marketing party--and send specialized reps to offer a few favors.
HHS and NIH take steps to enhance transparency of clinical trial results
20 November 2014
The U.S. Department of Health and Human Services today issued a Notice of Proposed Rulemaking (NPRM), which proposes regulations to implement reporting requirements for clinical trials that are subject to Title VIII of the Food and Drug Administration Amendments Act of 2007 (FDAAA).
US government proposes rules to increase transparency of clinical trials
20 November 2014
The US Department of Health and Human Services (HHS) proposed new rules on Wednesday that would increase the number of clinical trials that drugmakers, medical device companies and academic researchers are required to report. "We owe it to every participant and the public at large to support the maximal use of this knowledge for the greatest benefit to human health," remarked National Institutes of Health (NIH) director Francis Collins.
Cost to Develop a Drug More Than Doubles to $2.56 Billion
19 November 2014
It costs drugmakers $2.56 billion to bring a new medicine to market, on average, more than double the price of 11 years ago, according to a study released today. The higher cost comes from clinical trials that are larger and more complex, as well as more drugs that fail in development, according to the researchers. While the Food and Drug Administration is sometimes blamed for driving up costs because of the time it takes to review new drugs, that wasn’t a factor, according to the study by the Tufts Center for the Study of Drug Development.
18 November 2014
Russia’s Tomsk region known for its pharmaceuticals and chemicals have evinced interest for collaborations and joint ventures with Indian companies. A business delegation of small and medium companies from the Tomsk Region, Russia was here in Bengaluru, Mumbai and New Delhi to ascertain the growth prospects.
18 November 2014
Epic Sciences will present data describing the detection of clinically actionable non-small cell lung cancer (NSCLC) biomarkers, including EGFR, KRAS, ALK, MET, RET and ROS1, utilizing both circulating tumor cells (CTC) and circulating free DNA (cfDNA) from a single tube of blood. The poster presentation will take place on November 20 at the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona.
Innovation drug manufacturing site launched in Moscow
17 November 2014
A new production line has opened in Moscow’s Strogino Technopark to synthesize innovation drugs, the website of Moscow’s TVTs TV channel reported.
Kremlin opts not to sanction U.S.-Russia scientific ties, Russian ambassador said
17 November 2014
The Russian government is not imposing any sanctions whatsoever against the U.S. in the field of scientific interaction, Gazeta.ru reported, citing Ambassador Sergey Kislyak of the Russian Federation.
Putin signed a decree on the establishment of new health centers
17 November 2014
In 2015 in Moscow will have several national medical research centers. The corresponding decree was signed by Russian President Vladimir Putin said after meeting on federal funding of medical organizations. List of instructions published on the Kremlin website.
Merry Christmas and Happy New Year!
28 December 2024
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
The first Russian device for testing TB is registered
14 January 2025
Russians spend 1.6 trillion rubles on medications in 2024
14 January 2025
2024 drug approvals: Small companies loom large with several key FDA nods
13 January 2025
Special Regulations for Foreign-Packaged Medicines Extended Until the End of 2025
13 January 2025